JAMA Internal Medicine study examines the safety of GLP-1 receptor agonists and other second-line antidiabetic medications during early pregnancy, finding no significant increase in congenital anomalies compared to insulin use.
InStride Health Secures $30M to Expand Access to Pediatric Mental Healthcare
What You Should Know: – InStride Health, a leader in outpatient treatment for childhood anxiety and OCD closes oversubscribed $30M Series B funding round led
March 27, 2024